Aharon Schwartz insider trades: Protalix BioTherapeutics (PLX) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Aharon reports to the SEC
Open-market buys and sales
4 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 10, 2025 | PLX | ↑ Buy | 129,000 | $1.60 | $206K | Direct | Aug 12, 2025 (63d) |
| Jan 3, 2023 | PLX | ↑ Buy | 110,000 | $1.42 | $156K | Direct | Jan 5, 2023 (2d) |
| Apr 7, 2020 | PLX | ↑ Buy | 64,000 | $2.43 | $155K | Direct | Apr 13, 2020 (6d) |
| Nov 28, 2018 | FOMX | ↑ Buy | 112,200 | $3.90 | $438K | Direct | Dec 6, 2018 (8d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other PLX insiders
Open-market trades in the last 12 months
About Aharon Schwartz's insider trades
Aharon Schwartz is an insider at Protalix BioTherapeutics (PLX). Since Nov 28, 2018, Aharon has reported 4 open-market purchases worth $955K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (7 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every PLX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.